201 related articles for article (PubMed ID: 37024509)
1. Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitis.
Makar TK; Guda PR; Ray S; Andhavarapu S; Keledjian K; Gerzanich V; Simard JM; Nimmagadda VKC; Bever CT
Sci Rep; 2023 Apr; 13(1):5635. PubMed ID: 37024509
[TBL] [Abstract][Full Text] [Related]
2. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
Aharoni R; Eilam R; Lerner S; Shavit-Stein E; Dori A; Chapman J; Arnon R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948217
[TBL] [Abstract][Full Text] [Related]
4. Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells.
Abdurasulova IN; Matsulevich AV; Tarasova EA; Kudryavtsev IV; Serebrjakova MK; Ermolenko EI; Bisaga GN; Klimenko VM; Suvorov AN
Benef Microbes; 2016 Nov; 7(5):719-729. PubMed ID: 27633171
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.
LoPresti P
Neurochem Res; 2015 Mar; 40(3):473-9. PubMed ID: 25481047
[TBL] [Abstract][Full Text] [Related]
6. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
[TBL] [Abstract][Full Text] [Related]
7. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis.
Aharoni R; Eilam R; Schottlender N; Radomir L; Leistner-Segal S; Feferman T; Hirsch D; Sela M; Arnon R
J Neuroimmunol; 2020 Aug; 345():577281. PubMed ID: 32534388
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis.
Koc Ü; Haupeltshofer S; Klöster K; Demir S; Gold R; Faissner S
Cells; 2023 Feb; 12(4):. PubMed ID: 36831209
[No Abstract] [Full Text] [Related]
12. The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model.
Marques KB; Scorisa JM; Zanon R; Freria CM; Santos LM; Damasceno BP; Oliveira AL
Braz J Med Biol Res; 2009 Feb; 42(2):179-88. PubMed ID: 19274346
[TBL] [Abstract][Full Text] [Related]
13. Ac-SDKP ameliorates the progression of experimental autoimmune encephalomyelitis via inhibition of ER stress and oxidative stress in the hippocampus of C57BL/6 mice.
Pejman S; Kamarehei M; Riazi G; Pooyan S; Balalaie S
Brain Res Bull; 2020 Jan; 154():21-31. PubMed ID: 31589901
[TBL] [Abstract][Full Text] [Related]
14.
Lima C; Maleski ALA; Bernardo JTG; Zelli VC; Komegae EN; Lopes-Ferreira M
Front Immunol; 2022; 13():857692. PubMed ID: 35401524
[No Abstract] [Full Text] [Related]
15. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
[TBL] [Abstract][Full Text] [Related]
16. Glatiramer Acetate: from Bench to Bed and Back.
Arnon R; Aharoni R
Isr Med Assoc J; 2019 Mar; 21(3):151-157. PubMed ID: 30905097
[TBL] [Abstract][Full Text] [Related]
17. Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis.
Rahiman N; Zamani P; Arabi L; Alavizadeh SH; Nikpoor A; Mashreghi M; Badiee A; Jaafari MR
Int J Pharm; 2023 Dec; 648():123620. PubMed ID: 37981250
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate.
Aharoni R; Schottlender N; Bar-Lev DD; Eilam R; Sela M; Tsoory M; Arnon R
Sci Rep; 2019 Mar; 9(1):4140. PubMed ID: 30858445
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis.
Ortíz GG; Briones-Torres AL; Benitez-King G; González-Ortíz LJ; Palacios-Magaña CV; Pacheco-Moisés FP
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807462
[TBL] [Abstract][Full Text] [Related]
20. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Arnon R; Eilam R
J Neurosci; 2005 Sep; 25(36):8217-28. PubMed ID: 16148229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
